104 related articles for article (PubMed ID: 366454)
1. Therapeutic trial of tilorone in ALS: lack of benefit in a double-blind, placebo-controlled study.
Olson WH; Simons JA; Halaas GW
Neurology; 1978 Dec; 28(12):1293-5. PubMed ID: 366454
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis.
Lacomblez L; Bouche P; Bensimon G; Meininger V
Neurology; 1989 Dec; 39(12):1635-7. PubMed ID: 2685660
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside therapy for amyotrophic lateral sclerosis: a double-blind controlled trial.
Harrington H; Hallett M; Tyler HR
Neurology; 1984 Aug; 34(8):1083-5. PubMed ID: 6379507
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Meininger V; Genge A; van den Berg LH; Robberecht W; Ludolph A; Chio A; Kim SH; Leigh PN; Kiernan MC; Shefner JM; Desnuelle C; Morrison KE; Petri S; Boswell D; Temple J; Mohindra R; Davies M; Bullman J; Rees P; Lavrov A;
Lancet Neurol; 2017 Mar; 16(3):208-216. PubMed ID: 28139349
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
6. Effects of tilorone hydrochloride on experimental flavivirus infections in mice.
Vargin VV; Zschiesche W; Semenov BF
Acta Virol; 1977 Mar; 21(2):114-8. PubMed ID: 17279
[TBL] [Abstract][Full Text] [Related]
7. Trial of octacosanol in amyotrophic lateral sclerosis.
Norris FH; Denys EH; Fallat RJ
Neurology; 1986 Sep; 36(9):1263-4. PubMed ID: 3528918
[TBL] [Abstract][Full Text] [Related]
8. Keratopathy after oral administration of tilorone hydrochloride.
Weiss JN; Weinberg RS; Regelson W
Am J Ophthalmol; 1980 Jan; 89(1):46-53. PubMed ID: 6243446
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of tilorone hydrochloride on a transplantable rat adenocarcinoma.
Kellen JA; Mirakian A
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):185-8. PubMed ID: 7291725
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antiviral properties in mice of bis-pyrrolidinoacetamido-fluorenone (MLU-B75), bis-dipropylaminoacetamido-fluorenone (MLU-B76), and tilorone hydrochloride.
Veckenstedt A; Witkowski W; Hoffmann S
Acta Virol; 1979 Mar; 23(2):153-8. PubMed ID: 39439
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of nimodipine in amyotrophic lateral sclerosis.
Miller RG; Shepherd R; Dao H; Khramstov A; Mendoza M; Graves J; Smith S
Neuromuscul Disord; 1996 Mar; 6(2):101-4. PubMed ID: 8664560
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.
Cudkowicz ME; Shefner JM; Schoenfeld DA; Brown RH; Johnson H; Qureshi M; Jacobs M; Rothstein JD; Appel SH; Pascuzzi RM; Heiman-Patterson TD; Donofrio PD; David WS; Russell JA; Tandan R; Pioro EP; Felice KJ; Rosenfeld J; Mandler RN; Sachs GM; Bradley WG; Raynor EM; Baquis GD; Belsh JM; Novella S; Goldstein J; Hulihan J;
Neurology; 2003 Aug; 61(4):456-64. PubMed ID: 12939417
[TBL] [Abstract][Full Text] [Related]
13. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
Fitzwilliam JF; Griffith JF
J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
[TBL] [Abstract][Full Text] [Related]
14. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
[TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.
Blin O; Pouget J; Aubrespy G; Guelton C; Crevat A; Serratrice G
J Neurol; 1992 Feb; 239(2):79-81. PubMed ID: 1313078
[TBL] [Abstract][Full Text] [Related]
16. Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial.
Park SB; Vucic S; Cheah BC; Lin CS; Kirby A; Mann KP; Zoing MC; Winhammar J; Kiernan MC
EBioMedicine; 2015 Dec; 2(12):1916-22. PubMed ID: 26844270
[TBL] [Abstract][Full Text] [Related]
17. Double-blind controlled trial of purified brain gangliosides in amyotrophic lateral sclerosis and experience with peripheral neuropathies.
Bradley WG
Adv Exp Med Biol; 1984; 174():565-73. PubMed ID: 6331136
[TBL] [Abstract][Full Text] [Related]
18. VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics.
Andrews JA; Cudkowicz ME; Hardiman O; Meng L; Bian A; Lee J; Wolff AA; Malik FI; Shefner JM
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):259-266. PubMed ID: 29402141
[TBL] [Abstract][Full Text] [Related]
19. Modified snake venom in amyotrophic lateral sclerosis. Lack of clinical effectiveness.
Rivera VM; Grabois M; Deaton W; Breitbach W; Hines M
Arch Neurol; 1980 Apr; 37(4):201-3. PubMed ID: 7362484
[TBL] [Abstract][Full Text] [Related]
20. Retinopathy after tilorone hydrochloride.
Weiss JN; Ochs AL; Abedi S; Selhorst JB
Am J Ophthalmol; 1980 Dec; 90(6):846-53. PubMed ID: 7446671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
